Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian C Evans

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|June 12, 2015
MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasiaBrian C Evans, Kyle M Hocking, Michael J Osgood, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2018
Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexesAlvin J Mukalel, Brian C Evans, Kameron V Kilchrist, et al.
JCI Insight|October 8, 2021
Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switchJ William Tierney, Brian C Evans, Joyce Cheung-Flynn, et al.
Journal of Visualized Experiments : Jove|March 26, 2013
Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugsBrian C Evans, Christopher E Nelson, Shann S Yu, et al.
ACS Nano|January 11, 2019
Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular BioavailabilityKameron V Kilchrist, Somtochukwu C Dimobi, Meredith A Jackson, et al.
Nature Communications|November 3, 2019
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticlesBrian C Evans, R Brock Fletcher, Kameron V Kilchrist, et al.
ACS Nano|August 15, 2023
Nonviral <i>In Vivo</i> Delivery of CRISPR-Cas9 Using Protein-Agnostic, High-Loading Porous Silicon and Polymer NanoparticlesR Brock Fletcher, Larry D Stokes, Isom B Kelly, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Science Translational Medicine|June 12, 2015
MK2 inhibitory peptide delivered in nanopolyplexes prevents vascular graft intimal hyperplasiaBrian C Evans, Kyle M Hocking, Michael J Osgood, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 1, 2018
Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexesAlvin J Mukalel, Brian C Evans, Kameron V Kilchrist, et al.
JCI Insight|October 8, 2021
Therapeutic MK2 inhibition blocks pathological vascular smooth muscle cell phenotype switchJ William Tierney, Brian C Evans, Joyce Cheung-Flynn, et al.
Journal of Visualized Experiments : Jove|March 26, 2013
Ex vivo red blood cell hemolysis assay for the evaluation of pH-responsive endosomolytic agents for cytosolic delivery of biomacromolecular drugsBrian C Evans, Christopher E Nelson, Shann S Yu, et al.
ACS Nano|January 11, 2019
Gal8 Visualization of Endosome Disruption Predicts Carrier-Mediated Biologic Drug Intracellular BioavailabilityKameron V Kilchrist, Somtochukwu C Dimobi, Meredith A Jackson, et al.
Nature Communications|November 3, 2019
An anionic, endosome-escaping polymer to potentiate intracellular delivery of cationic peptides, biomacromolecules, and nanoparticlesBrian C Evans, R Brock Fletcher, Kameron V Kilchrist, et al.
ACS Nano|August 15, 2023
Nonviral <i>In Vivo</i> Delivery of CRISPR-Cas9 Using Protein-Agnostic, High-Loading Porous Silicon and Polymer NanoparticlesR Brock Fletcher, Larry D Stokes, Isom B Kelly, et al.
Pageof 2